Wellington Management Group LLP Has $6.78 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Key Points

• Wellington Management Group LLP increased its stake in GE HealthCare Technologies by 245.0% in Q1, acquiring an additional 59,626 shares, bringing its total holdings to 83,967 shares valued at approximately $6.8 million.
• Several hedge funds have also modified their positions, with institutional investors now owning 82.06% of GE HealthCare Technologies stock.
• Analysts have mixed projections for the company, with a consensus rating of "Moderate Buy" and a price target averaging $88.55, following earnings that beat estimates with EPS of $1.06.

Wellington Management Group LLP lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 245.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 83,967 shares of the company's stock after acquiring an additional 59,626 shares during the period. Wellington Management Group LLP's holdings in GE HealthCare Technologies were worth $6,777,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. N.E.W. Advisory Services LLC bought a new stake in shares of GE HealthCare Technologies during the first quarter worth $25,000. Bogart Wealth LLC grew its position in GE HealthCare Technologies by 260.0% in the first quarter. Bogart Wealth LLC now owns 342 shares of the company's stock valued at $28,000 after purchasing an additional 247 shares in the last quarter. Stonebridge Financial Group LLC grew its position in GE HealthCare Technologies by 165.7% in the first quarter. Stonebridge Financial Group LLC now owns 356 shares of the company's stock valued at $29,000 after purchasing an additional 222 shares in the last quarter. Accredited Wealth Management LLC bought a new position in GE HealthCare Technologies in the fourth quarter valued at $30,000. Finally, LGT Financial Advisors LLC grew its position in GE HealthCare Technologies by 46.2% in the fourth quarter. LGT Financial Advisors LLC now owns 389 shares of the company's stock valued at $30,000 after purchasing an additional 123 shares in the last quarter. Institutional investors own 82.06% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on GEHC. Morgan Stanley decreased their price objective on shares of GE HealthCare Technologies from $78.00 to $74.00 and set an "equal weight" rating for the company in a research report on Thursday, July 31st. Wall Street Zen raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating in a research report on Saturday, May 31st. UBS Group raised shares of GE HealthCare Technologies from a "sell" rating to a "neutral" rating and decreased their price objective for the company from $74.00 to $73.00 in a research report on Monday, May 5th. BTIG Research restated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Finally, Zacks Research upgraded shares of GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. One equities research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating and three have given a Hold rating to the company's stock. According to data from MarketBeat, GE HealthCare Technologies currently has an average rating of "Moderate Buy" and a consensus price target of $88.55.

GE HealthCare Technologies Stock Performance

NASDAQ GEHC traded down $2.27 during trading on Tuesday, reaching $71.46. The company's stock had a trading volume of 1,907,508 shares, compared to its average volume of 3,957,401. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85. The firm has a market capitalization of $32.63 billion, a price-to-earnings ratio of 14.65, a price-to-earnings-growth ratio of 2.82 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12 month low of $57.65 and a 12 month high of $94.80. The firm has a 50 day moving average price of $74.28 and a 200 day moving average price of $74.42.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. The firm had revenue of $5 billion during the quarter, compared to the consensus estimate of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business's revenue for the quarter was up 3.5% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.00 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 25th were given a $0.035 dividend. The ex-dividend date was Friday, July 25th. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies's payout ratio is presently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.